FTC “Barrs” Firm From Anticompetitive Agreements
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Trade Commission gets rare victory in settlement with Barr over charges that cash payment delayed entry of generic Ovcon.
You may also be interested in...
Pharmas Should Be Less Aggressive With Reverse Payments, Former FTC Counsel Advises
Payments to delay generic entry could be banned under pending legislation before Congress.
FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers
Commission settles charges against the brand drug maker related to generic Ovcon 35.
Supreme Court Denies Certiorari To FTC v. Schering-Plough
The high court denies the Federal Trade Commission’s petition to hear the case regarding issues raised by brand companies’ reverse payments to generic firms.